Display options
Cite
Hall IH, Williams WL, Rhyne KA, et al. The hypolipidemic activity of furoic Acid and furylacrylic Acid derivatives in rodents. Pharm Res. 1985;2(5):233-8doi: 10.1023/A:1016368912659.
Hall, I. H., Williams, W. L., Rhyne, K. A., & Knowles, M. (1985). The hypolipidemic activity of furoic Acid and furylacrylic Acid derivatives in rodents. Pharmaceutical research, 2(5), 233-8. https://doi.org/10.1023/A:1016368912659
Hall, I H, et al. "The hypolipidemic activity of furoic Acid and furylacrylic Acid derivatives in rodents." Pharmaceutical research vol. 2,5 (1985): 233-8. doi: https://doi.org/10.1023/A:1016368912659
Hall IH, Williams WL, Rhyne KA, Knowles M. The hypolipidemic activity of furoic Acid and furylacrylic Acid derivatives in rodents. Pharm Res. 1985 Sep;2(5):233-8. doi: 10.1023/A:1016368912659. PMID: 24272843.
Copy Download .nbib Format: NLM
Share it on

Pharm Res. 1985 Sep;2(5):233-8. doi: 10.1023/A:1016368912659.

The hypolipidemic activity of furoic Acid and furylacrylic Acid derivatives in rodents.

Pharmaceutical research

I H Hall, W L Williams, K A Rhyne, M Knowles

Affiliations

  1. Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, N.C, 27514.

PMID: 24272843 DOI: 10.1023/A:1016368912659

Abstract

2-Furoic acid, 3-furoic acid, 3,4-furan dicarboxylic acid and furyl-acrylic acid were evaluated for hypolipidemic activity in mice and rats. 2-Furoic acid was the most potent agent of the four tested, lowering serum cholesterol levels 41 % and serum triglyceride levels 56 % at 20 mg/kg/day in mice and serum cholesterol 50 % and serum triglyceride levels 42 % in rats. 2-Furoic acid effectively suppressed liver mitochondrial citrate exchange, ATP dependent citrate lyase, acetyl CoA synthetase, acyl CoA cholesterol acyl transferase, sn-glycerol-3-phosphate acyl transferase, phosphatidate phosphohydrolase and hepatic lipoprotein lipase enzymatic activities. Lipid levels after 16 days in mice were reduced in the liver. In the rat cholesterol content of the HDL fraction was elevated and lowered in the chylomicron fraction. 2-Furoic acid administration for 14 days resulted in a large portion of (3)H-cholesterol being excreted by the biliary route. The furoic acid derivatives appear to have promise as hypolipidemic agents and further studies on their ability to lower lipids are warranted.

References

  1. Res Commun Chem Pathol Pharmacol. 1973 Jul;6(1):253-62 - PubMed
  2. J Biol Chem. 1968 Dec 10;243(23):6273-80 - PubMed
  3. J Biochem. 1969 Feb;65(2):171-5 - PubMed
  4. Adv Lipid Res. 1968;6:1-68 - PubMed
  5. J Pharm Sci. 1981 Mar;70(3):326-8 - PubMed
  6. Can J Biochem Physiol. 1959 Aug;37(8):911-7 - PubMed
  7. J Pharmacol Exp Ther. 1949 Jun;96(2):99-113 - PubMed
  8. J Med Chem. 1974 Jan;17(1):108-12 - PubMed
  9. J Med Chem. 1972 Jun;15(6):659-62 - PubMed
  10. Lancet. 1981 Aug 29;2(8244):478 - PubMed
  11. J Pharm Sci. 1984 Oct;73(10):1482-4 - PubMed
  12. Lipids. 1976 Aug;11(8):610-5 - PubMed
  13. Lipids. 1976 May;11(5):384-91 - PubMed
  14. J Biol Chem. 1951 Jun;190(2):513-7 - PubMed
  15. J Clin Invest. 1955 Sep;34(9):1345-53 - PubMed
  16. J Pharm Sci. 1983 Jul;72(7):812-4 - PubMed
  17. Clin Chim Acta. 1964 Sep;10:229-37 - PubMed
  18. J Lipid Res. 1968 May;9(3):328-33 - PubMed
  19. Eur J Biochem. 1970 Aug;15(2):263-72 - PubMed
  20. J Med Chem. 1983 Feb;26(2):237-43 - PubMed
  21. Biochim Biophys Acta. 1970 Aug 4;216(1):63-70 - PubMed
  22. J Biol Chem. 1973 Jun 25;248(12):4318-26 - PubMed
  23. J Med Chem. 1977 Jun;20(6):781-91 - PubMed
  24. J Lipid Res. 1978 May;19(4):467-77 - PubMed
  25. Biochem J. 1935 Jul;29(7):1683-9 - PubMed
  26. Anal Biochem. 1978 Feb;84(2):441-8 - PubMed
  27. J Pharm Sci. 1983 Aug;72(8):845-51 - PubMed
  28. Atherosclerosis. 1977 Jun;27(2):147-54 - PubMed
  29. J Clin Invest. 1982 Feb;69(2):490-3 - PubMed
  30. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  31. Eur J Biochem. 1978 Oct;90(2):377-83 - PubMed

Publication Types